Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Merck eyes larger Merial
FT.com
Monday, September 21, 2009 - 9:16am
tags:
Merck, Merial, Sanofi, M&A, veterinary medicine
Bayer, Onyx’s Nexavar Drug Helps Slow Breast Cancer Progression
Bloomberg
Monday, September 21, 2009 - 9:15am
tags:
Nexavar, Bayer, ONYX Pharmaceuticals, breast cancer
In Lilly's pipeline: Profit or Peril?
Indianapolis Star, IN
Sunday, September 20, 2009 - 12:34pm
tags:
Eli Lilly, pipelines
Sun Pharma to file 30 applications for generic drugs in US
Economic Times, India
Sunday, September 20, 2009 - 12:33pm
tags:
Sun Pharma, India
2 Can Play That Game: Pfizer Claims Witness-Tampering in Neurontin Case
BNET Pharma
Sunday, September 20, 2009 - 12:31pm
tags:
Pfizer, Neurontin, lawsuits
FDA approves new HIV test from Abbott Laboratories
Yahoo/AP
Saturday, September 19, 2009 - 9:59am
tags:
Abbott Laboratories, HIV
Immunosyn Refutes Unfounded Rumors in Marketplace
GlobeNewswire
Saturday, September 19, 2009 - 9:56am
tags:
Immunosyn
Health-Care Stocks That Have A Good Prognosis
Washington Post
Saturday, September 19, 2009 - 9:47am
tags:
Teva Pharmaceuticals, JNJ, Covance
GENova Bio ends relationship with Bridge BioResearch
Street Insider
Saturday, September 19, 2009 - 9:45am
tags:
GENova Bio, Bridge Bioresearch
Spectrum Pharmaceuticals to Raise up to $50 Million from Institutional Investors at $7.55 Per Share
Yahoo/BusinessWire
Saturday, September 19, 2009 - 9:42am
tags:
Spectrum Pharmaceuticals
Schering-Plough declares dividend of 6.5 cents
Yahoo/AP
Saturday, September 19, 2009 - 9:39am
tags:
Schering Plough
Novartis Drug Gets FDA OK
Yahoo/Zacks
Saturday, September 19, 2009 - 9:38am
tags:
Novartis, Valturna, Diovan, Tekturna
PDL BioPharma Announces Conversion Rate Adjustment for Its 2.75% Convertible Subordinated Notes Due August 16, 2023
PR NewsWire
Saturday, September 19, 2009 - 9:36am
tags:
PDL Biopharma
Metabasis Therapeutics Receives Notice of Noncompliance with Nasdaq Listing Requirements
Business Wire
Saturday, September 19, 2009 - 9:35am
tags:
Metabasis
La Jolla Pharmaceutical Company Receives Notice of Noncompliance with Nasdaq Stock Market Listing Requirement
Business Wire
Saturday, September 19, 2009 - 9:34am
tags:
La Jolla Pharmaceutical
Genzyme's MS Drug Shows Promise
Seeking Alpha
Friday, September 18, 2009 - 11:20am
tags:
Genzyme, multiple sclerosis, MS, alemtuzumab
Is the biotech venture glass half empty or half full?
Fierce Biotech
Friday, September 18, 2009 - 11:19am
tags:
biotech, venture capital
Hospira Ups 2009 Guidance
Yahoo/Zacks.com
Friday, September 18, 2009 - 11:18am
tags:
Hospira, GSK, Baxter International, H1N1
Dr. Reddy’s Climbs on Glaxo Stake Purchase Report
Bloomberg
Friday, September 18, 2009 - 11:16am
tags:
GSK, Dr Reddy's, M&A
The Next Biopharma M&A Targets
Barron's
Friday, September 18, 2009 - 11:11am
tags:
M&A, Bristol-Myers Squibb, Eli Lilly, AstraZeneca, Abbott Laboratories, JNJ, Novartis, Sanofi

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.